SVFC $$$$ It's coming....listen to the Dr; "more good to come"....and when it hits this undervalued shining star is going to BLAST OFF!!:)
Let's look at what the US Patent Office, Millipore Coorporation, European Patent Office, Patent Cooperation Treaty, and member of SVFC advisory board, Dr. Zain Khalpey(cardiac surgeon and leader in the field of Stem Cell and Regenerative Medicine), has to say about SVFC Patented Stem Cell Technology:)...to mention just a few:)
Quote: "I believe that with the use of cavitation technology to harvest the stromal vascular fraction from a lipoaspirate without chemicals and enzymes, we would be able to capture the appropriate stem cells with their micromatrix and microenvironment for use in patients with failing hearts and lungs."
In his research role at the UA, he is the director of the Ex Vivo Lung Program, clinical and translational research, and the Cardiopulmonary Stem Cell Bank. Dr. Khalpey also holds a position on the UA Institutional Review Board (IRB).
He also is involved in creating clinical “bridge-to-regeneration” trials, in which autologous stem cells will be injected into failing hearts with the hope of recovery in an era of limited hearts for transplantation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.